Paradigm Biopharmaceuticals Ltd.ASX: PAR

Convening Period Extended to 27 January 2027

· Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

This extension was approved by the Supreme Court of Western Australia and allows the administrators to address outstanding matters before the meeting. The administrators anticipate being able to issue the Voluntary Administrators’ Report and convene the meeting sooner than the extended deadline.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/convening-period-extended-to-27-january-2027-1

Release

28 October 2026 ASX Announcement Paradigm Biopharmaceuticals Limited ACN 169 346 963 (Administrators Appointed) Convening Period for Second Meeting of Creditors Extended to 27 January 2027 We refer to the appointment of Christopher Pattinson and Hayden White as Joint and Several Voluntary...

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

Later from Paradigm Biopharmaceuticals

All Paradigm Biopharmaceuticals news releases